X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28279) 28279
Book Chapter (82) 82
Book / eBook (24) 24
Publication (14) 14
Dissertation (8) 8
Magazine Article (4) 4
Conference Proceeding (3) 3
Streaming Video (3) 3
Web Resource (3) 3
Book Review (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23602) 23602
oncology (13022) 13022
female (10316) 10316
male (8227) 8227
middle aged (7446) 7446
chemotherapy (7236) 7236
randomized controlled trials as topic (7072) 7072
treatment outcome (6862) 6862
aged (6716) 6716
randomized-trial (6588) 6588
cancer (6392) 6392
adult (6207) 6207
antineoplastic combined chemotherapy protocols - therapeutic use (4923) 4923
care and treatment (4655) 4655
clinical trials (3949) 3949
randomized controlled-trial (3759) 3759
pharmacology & pharmacy (3635) 3635
medicine & public health (3312) 3312
double-blind (3247) 3247
antineoplastic agents - therapeutic use (3011) 3011
research (2979) 2979
radiotherapy (2763) 2763
surgery (2748) 2748
phase-ii (2607) 2607
therapy (2567) 2567
randomized trial (2482) 2482
phase-ii trial (2480) 2480
prognosis (2431) 2431
neoplasm staging (2401) 2401
health aspects (2368) 2368
survival (2350) 2350
drug therapy (2341) 2341
analysis (2335) 2335
cisplatin (2297) 2297
combined modality therapy (2293) 2293
animals (2289) 2289
aged, 80 and over (2217) 2217
disease-free survival (2108) 2108
survival analysis (2051) 2051
randomized phase-ii (2034) 2034
clinical trials as topic (1914) 1914
hematology, oncology and palliative medicine (1896) 1896
survival rate (1887) 1887
antineoplastic combined chemotherapy protocols - adverse effects (1864) 1864
metastasis (1860) 1860
lung neoplasms - drug therapy (1846) 1846
carcinoma (1821) 1821
risk factors (1752) 1752
radiation-therapy (1740) 1740
patients (1730) 1730
clinical trials, phase ii as topic (1725) 1725
hematology (1669) 1669
breast cancer (1657) 1657
carcinoma, non-small-cell lung - drug therapy (1547) 1547
drug administration schedule (1538) 1538
review (1530) 1530
breast neoplasms - drug therapy (1495) 1495
efficacy (1489) 1489
quality of life (1455) 1455
open-label (1428) 1428
quality-of-life (1422) 1422
retrospective studies (1418) 1418
clinical trials, phase iii as topic (1404) 1404
chemotherapy, adjuvant (1401) 1401
trial (1381) 1381
1st-line treatment (1379) 1379
medicine, general & internal (1346) 1346
time factors (1328) 1328
studies (1326) 1326
docetaxel (1284) 1284
cisplatin - administration & dosage (1282) 1282
combination (1282) 1282
follow-up studies (1274) 1274
randomized phase-iii (1261) 1261
phase-iii trial (1256) 1256
safety (1233) 1233
paclitaxel (1222) 1222
antineoplastic combined chemotherapy protocols - administration & dosage (1215) 1215
fluorouracil (1215) 1215
colorectal cancer (1205) 1205
medical research (1204) 1204
cancer therapies (1202) 1202
immunotherapy (1202) 1202
internal medicine (1201) 1201
bevacizumab (1196) 1196
tumors (1193) 1193
dose-response relationship, drug (1188) 1188
fluorouracil - administration & dosage (1173) 1173
prospective studies (1173) 1173
usage (1162) 1162
neoplasm metastasis (1160) 1160
medicine, research & experimental (1155) 1155
adolescent (1150) 1150
clinical neurology (1114) 1114
medicine (1112) 1112
antineoplastic agents - administration & dosage (1103) 1103
adjuvant chemotherapy (1099) 1099
antineoplastic agents - adverse effects (1069) 1069
mortality (1067) 1067
gemcitabine (1055) 1055
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Online Resources - Online (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Baycrest Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27914) 27914
French (271) 271
German (211) 211
Japanese (62) 62
Spanish (51) 51
Italian (25) 25
Portuguese (21) 21
Polish (14) 14
Chinese (7) 7
Russian (7) 7
Norwegian (5) 5
Turkish (5) 5
Hungarian (4) 4
Lithuanian (4) 4
Danish (2) 2
Dutch (2) 2
Korean (2) 2
Czech (1) 1
Finnish (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical cancer research, ISSN 1557-3265, 2009, Volume 15, Issue 6, pp. 1883 - 1890
...)and progression-free survival (PFS) but not necessarily tumor response, has increased in oncology, there has been a corresponding increase in the recommendation and use of randomized phase II designs... 
CLINICAL-TRIAL DESIGNS | METAANALYSIS | MELANOMA | ONCOLOGY | PROGRESSION-FREE SURVIVAL | COLORECTAL-CANCER | DISCONTINUATION DESIGN | TUMOR RESPONSE | END-POINTS | AGENTS | Neoplasms - mortality | Clinical Trials, Phase II as Topic - methods | Randomized Controlled Trials as Topic - methods | Research Design | Humans | Neoplasms - drug therapy
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2008, Volume 26, Issue 29, pp. 4714 - 4719
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2005, Volume 23, Issue 28, pp. 7199 - 7206
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2012, Volume 30, Issue 26, pp. 3304 - 3309
... (eg, enrichment designs and biomarker-stratified designs). Before proceeding to phase III, randomized phase II trials are often used to decide whether the new therapy warrants phase III testing... 
CELL LUNG-CANCER | ISSUES | CETUXIMAB | PLACEBO | BENEFIT | ONCOLOGY | COLORECTAL-CANCER | Sample Size | Humans | Biomarkers - analysis | Treatment Outcome | Research Design | Molecular Targeted Therapy - methods | Clinical Trials, Phase II as Topic | Randomized Controlled Trials as Topic | To2 | Bios3 | Statistics in Oncology
Journal Article
British journal of haematology, ISSN 0007-1048, 2015, Volume 169, Issue 5, pp. 672 - 682
Summary This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti... 
mogamulizumab | randomized phase II study | CCR4 | adult T‐cell leukaemia‐lymphoma | antibody therapy | Adult T-cell leukaemia-lymphoma | Mogamulizumab | Antibody therapy | Randomized phase II study | adult T-cell leukaemia-lymphoma | MONOCLONAL-ANTIBODY KW-0761 | RECEPTOR | LEUKEMIA/LYMPHOMA | HEMATOLOGY | EXPRESSION | ASSOCIATION | TRANSPLANTATION | Doxorubicin - therapeutic use | Nitrosourea Compounds - adverse effects | Prednisolone - adverse effects | Nitrosourea Compounds - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Carboplatin - therapeutic use | Vindesine - adverse effects | Vindesine - therapeutic use | Aged, 80 and over | Adult | Female | Prednisolone - therapeutic use | Etoposide - adverse effects | Leukemia-Lymphoma, Adult T-Cell - mortality | Etoposide - therapeutic use | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Chemotherapy | Lymphomas | T cells | Leukemia | Cancer | Haematological Malignancy | Research Paper
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2012, Volume 30, Issue 25, pp. 3119 - 3126
Journal Article
Journal Article